Identification |
Name: | [1,6]Dioxacyclododecino[2,3,4-gh]pyrrolizine-2,7-dione,3,4,5,6,9,11,13,14,14a,14b-decahydro-3,6-dihydroxy-3-(hydroxymethyl)-4,5,6-trimethyl-,(3S,4R,5R,6R,14aR,14bR)- (9CI) |
Synonyms: | 21-Norsenecionan-11,16-dione,15,20-dihydro-12,15,20-trihydroxy-14-methyl-, (14a,15a)-; Sceleratine (6CI,7CI,8CI); Sceleratin;[1,6]Dioxacyclododecino[2,3,4-gh]pyrrolizine-2,7-dione,3,4,5,6,9,11,13,14,14a,14b-decahydro-3,6-dihydroxy-3-(hydroxymethyl)-4,5,6-trimethyl-,[3S-(3R*,4S*,5S*,6S*,14aS*,14bS*)]- |
CAS: | 6190-25-6 |
Molecular Formula: | C18H27NO7 |
Molecular Weight: | 0 |
InChI: | InChI=1/C18H27NO7/c1-10-11(2)18(24,9-20)16(22)26-13-5-7-19-6-4-12(14(13)19)8-25-15(21)17(10,3)23/h4,10-11,13-14,20,23-24H,5-9H2,1-3H3/t10-,11?,13-,14?,17?,18?/m1/s1 |
Molecular Structure: |
|
Properties |
Transport: | 1544 |
Flash Point: | 305.5°C |
Boiling Point: | 581.5°C at 760 mmHg |
Density: | 1.36g/cm3 |
Refractive index: | 1.59 |
Packinggroup: | III |
Flash Point: | 305.5°C |
Safety Data |
|
|